WASHINGTON — As ubiquitous artificial intelligence models rapidly infiltrate clinical workflows, a profound regulatory reckoning is unfolding across state legislatures: should an algorithm be granted a medical license? On August 3, 2026, the leadership of the Federation of State Medical Boards (FSMB) delivered a definitive, unequivocal answer, arguing that AI is nowhere near ready to practice medicine independently.

In a sweeping policy directive published by STAT News, FSMB President and CEO Humayun Chaudhry and Board Chair Christy Valentine Theard dismantled the burgeoning movement to license AI as a standalone "practitioner." The authors assert that the very foundation of medical regulation rests upon a sacred social contract—one that algorithms simply cannot fulfill. "Medicine rests on a social contract: Society grants physicians unique privileges because they promise extraordinary duties of competence, ethics, and accountability in return," the leaders wrote.

"A medical license, therefore, isn’t just a permit to generate thoughtful and informed answers. It’s a legal and ethical grant of authority tied to human judgment, professional accountability, discipline, transparency, and a duty to put patients first." — Humayun Chaudhry & Christy Valentine Theard, FSMB Leadership

The intervention arrives at a critical juncture for healthcare policy. Across the United States, tech-forward pilot programs and draft state legislation have flirted with the idea of granting autonomy to diagnostic bots and generative AI models. The FSMB, representing all 69 state and territorial medical boards statutorily charged with protecting the public, views this trajectory as dangerously premature. Instead of creating a novel licensing category for software, the federation insists that generative AI must be governed strictly within existing professional and institutional accountability structures.

Under this framework, liability and oversight remain firmly anchored to the human clinicians and healthcare systems deploying the technology. The responsibility must be explicitly aligned with the AI's level of autonomy and the degree of human oversight present, rather than treating the software as a separate, licensed entity. This stance effectively shields the medical profession from a fragmented regulatory landscape where unaccountable algorithms could operate beyond the reach of traditional medical boards' disciplinary mechanisms.

As the healthcare sector hurtles toward an automated future, the FSMB’s policy guidance serves as a vital bulwark against the erosion of clinical ethics. By firmly tethering the practice of medicine to human judgment and moral accountability, state regulators are ensuring that while the tools of healing may evolve into silicon and code, the ultimate responsibility for patient survival remains unmistakably, and exclusively, human.